AAV–sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo-Reference-Cited by-同舟云学术

AAV–sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo

Published:2014-11 Issue:2 Volume:354 Page:398-406
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Han Lingfei,Wang Wei,Lu Jiahong,Kong Fanfei,Ma Ge,Zhu Yiping,Zhao Dong,Zhu Jianlong,Shuai Wen,Zhou Qian,Chen Ping,Ye Lei,Tao Jie,Ahmad Sarfraz,Li Fang,Sun Jing

Funder

National Natural Science Foundation of China

Shanghai Rising-Star Program

Science and Technology Commission of Shanghai Municipality

Health Bureau of Shanghai

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. The evolution of melanoma resistance reveals therapeutic opportunities;Das Thakur;Cancer Res,2013

2. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients;Radvanyi;Clin. Cancer Res,2012

3. Adoptive T-cell transfer therapy and oncogene-targeted therapy for melanoma: the search for synergy;Kwong;Clin. Cancer Res,2013

4. The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma;Kaufman;Nat. Rev. Clin. Oncol,2013

5. Melanoma immunotherapy using mature DCs expressing the constitutive proteasome;Dannull;J. Clin. Invest,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting BTLA with the peptide inhibitor HVEM(14-39) – A new way to restore the activity of T cells in melanoma;Biomedicine & Pharmacotherapy;2024-06

2. Development of Personalized Strategies for Precisely Battling Malignant Melanoma;International Journal of Molecular Sciences;2024-05-04

3. Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target;Frontiers in Oncology;2024-04-05

4. The BTLA-HVEM complex – The future of cancer immunotherapy;European Journal of Medicinal Chemistry;2024-03

5. HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances;Biomolecules;2023-03-27